Overview
- 111 inspections across 109 sites are on record.
- 587 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-17.
At a glance
Inspections
111
Sites
109
Observations
587
Career since
Jul 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Cipla Limited | 17 Apr 2026 | Human Drugs | On file |
| Symbiotec Pharmalab Limited | 3 Apr 2026 | Human Drugs | On file |
| MSD International GmbH (Singapore Branch) | 23 Jan 2026 | Human Drugs | On file |
| Life Science Outsourcing, Inc. | 11 Dec 2025 | Human Drugs | On file |
| Emballages Spectrum Inc. | 6 Nov 2025 | Human Drugs | On file |
Sites inspected
Cipla LimitedSalcette, India1 insp.
Symbiotec Pharmalab LimitedMhow, India1 insp.
MSD International GmbH (Singapore Branch)Singapore, Singapore1 insp.
Life Science Outsourcing, Inc.Brea, United States1 insp.
Emballages Spectrum Inc.Saint-Laurent, Canada1 insp.
Co-investigators
Investigators who share inspections with this person.
Linda F Murphy6 shared
Khoa Nathan V Tran5 shared
Anney Lin4 shared
Uttaniti Limchumroon4 shared
Roger F Zabinski4 shared
Dogbeda F Mackenzie4 shared
Anastasia M Shields3 shared
Darren S Brown3 shared
Scott N Lim3 shared
Joshua P Wireman3 shared
Full investigator report
Get the verbatim findings behind Jeffrey P Raimondi's 587 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site